Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Gold nanoparticles show promise for treating inflammatory bowel disease by reducing inflammation and colon injury.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Targeting ornithine decarboxylase can help prevent skin cancer.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

The formulated gel is a promising treatment for alopecia areata.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

ITK inhibitors may effectively treat alopecia areata.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Fosravuconazole effectively treated a woman's scalp infection without side effects.